Cargando…
Peripheral vein infusion of autologous mesenchymal stem cells in Egyptian HCV-positive patients with end-stage liver disease
INTRODUCTION: We have assessed the utility of autologous mesenchymal stem cell (MSC) peripheral vein infusion as a possible therapeutic modality for patients with end-stage liver diseases. METHODS: Forty patients with post-hepatitis C virus (HCV) end-stage liver disease were randomized into two grou...
Autores principales: | Salama, Hosny, Zekri, Abdel-Rahman N, Medhat, Eman, Al Alim, Shereen A, Ahmed, Ola S, Bahnassy, Abeer A, Lotfy, Mai M, Ahmed, Rasha, Musa, Sherief |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4097846/ https://www.ncbi.nlm.nih.gov/pubmed/24886681 http://dx.doi.org/10.1186/scrt459 |
Ejemplares similares
-
The impact of repeated autologous infusion of haematopoietic stem cells in patients with liver insufficiency
por: Zekri, Abdel-Rahman N., et al.
Publicado: (2015) -
Assessment of health-related quality of life in patients receiving stem cell therapy for end-stage liver disease: an Egyptian study
por: Salama, Hosny, et al.
Publicado: (2012) -
Consensus siRNA for inhibition of HCV genotype-4 replication
por: Zekri, Abdel Rahman N, et al.
Publicado: (2009) -
Investigation of chromosomal aberrations in Egyptian hepatocellular carcinoma patients by fluorescence in situ hybridization
por: Aly, Magdy S., et al.
Publicado: (2010) -
The possible role of Dickkopf-1, Golgi protein- 73 and Midkine as predictors of hepatocarcinogenesis: a review and an Egyptian study
por: N Zekri, Abdel-Rahman, et al.
Publicado: (2020)